- Home
- FRGT vs APVO Comparison
FRGT vs APVO Comparison
Compare FRGT & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- APVO
- Stock Information
- Founded
- FRGT 2015
- APVO 2016
- Country
- FRGT Mexico
- APVO United States
- Employees
- FRGT N/A
- APVO N/A
- Industry
- FRGT Professional Services
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- FRGT Consumer Discretionary
- APVO Health Care
- Exchange
- FRGT Nasdaq
- APVO Nasdaq
- Market Cap
- FRGT 4.2M
- APVO 4.1M
- IPO Year
- FRGT N/A
- APVO N/A
- Fundamental
- Price
- FRGT $1.50
- APVO $2.68
- Analyst Decision
- FRGT
- APVO Strong Buy
- Analyst Count
- FRGT 0
- APVO 1
- Target Price
- FRGT N/A
- APVO $5,920.00
- AVG Volume (30 Days)
- FRGT 215.3K
- APVO 151.0K
- Earning Date
- FRGT 08-16-2025
- APVO 08-11-2025
- Dividend Yield
- FRGT N/A
- APVO N/A
- EPS Growth
- FRGT N/A
- APVO N/A
- EPS
- FRGT N/A
- APVO N/A
- Revenue
- FRGT $13,541,802.00
- APVO N/A
- Revenue This Year
- FRGT $371.03
- APVO N/A
- Revenue Next Year
- FRGT N/A
- APVO N/A
- P/E Ratio
- FRGT N/A
- APVO N/A
- Revenue Growth
- FRGT N/A
- APVO N/A
- 52 Week Low
- FRGT $1.45
- APVO $2.65
- 52 Week High
- FRGT $23.50
- APVO $381.10
- Technical
- Relative Strength Index (RSI)
- FRGT 31.41
- APVO 33.13
- Support Level
- FRGT $1.67
- APVO $2.84
- Resistance Level
- FRGT $1.80
- APVO $2.96
- Average True Range (ATR)
- FRGT 0.17
- APVO 0.14
- MACD
- FRGT -0.01
- APVO 0.09
- Stochastic Oscillator
- FRGT 6.17
- APVO 4.62
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.